drug · antibody
pasritamig
Phase 3updated 7mo agoby $JNJ JOHNSON & JOHNSON🔗 ChEMBL
Phase 3community read0 votes
Antibody drug with a maximum clinical stage of Phase 3 (across all indications), with 4 investigational indications.
all catalysts(0)
nothing on the calendar yet
Trials studying pasritamig
- phase2A Study of Tagmokitug in Combination With Other Treatments in Participants With Advanced or Metastatic Solid Tumors
- phase3A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
- phase3A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- phase1A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer
- phase1A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
News(1)
- Coherus shrinks headcount 30% to narrow focus of cancer comboCoherus Oncology is once again laying off 30% of its workforce as the biopharma narrows the focus of its CCR8-targeting antibody on esophageal cancer.fiercebiotech · 11d ago
Data sources
last refreshed 37m ago
Found something off?
comments(0)
5-min edit window · permanent after that